Market Place
Sourcing Support
Sutro Biopharma Reports Full Year 2025 Financial Results
23 Mar 2026 //
GLOBENEWSWIRE
Sutro Bio To Attend 16Th World ADC London Summit
23 Feb 2026 //
GLOBENEWSWIRE
Sutro Bio Complies With Nasdaq Minimum Bid Price Rule
17 Dec 2025 //
GLOBENEWSWIRE
Sutro Bio Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)
16 Dec 2025 //
GLOBENEWSWIRE
Sutro Bio Doses First Patients In STRO-004, Phase 1 Trial
03 Dec 2025 //
GLOBENEWSWIRE
Sutro Bio Showcases Advanced ADC Innovation At Virtual R&D Event
12 Nov 2025 //
GLOBENEWSWIRE
Sutro Bio Reveals Q3 2025 Financials & Business Highlights
06 Nov 2025 //
GLOBENEWSWIRE
Sutro Bio Plans Virtual R&D Day On Nov 12, 2025
05 Nov 2025 //
GLOBENEWSWIRE
Sutro Bio To Attend 16th World ADC Conference
03 Nov 2025 //
GLOBENEWSWIRE
Sutro Loses 3rd Of Workforce In 2nd Round Of Layoffs This Year
30 Sep 2025 //
FIERCE BIOTECH
Sutro Bio Initiates Restructuring To Extend Cash Runway
29 Sep 2025 //
GLOBENEWSWIRE
Sutro Biopharma Unveils Q2 2025 Financials and Business Updates
07 Aug 2025 //
GLOBENEWSWIRE
Sutro Bio, FDA Collaborate to Advance Antibody Drug Standards
22 Jul 2025 //
GLOBENEWSWIRE
Sutro Biopharma to Present Next-Gen Exatecan at AACR 2025
28 Apr 2025 //
GLOBENEWSWIRE
Sutro Biopharma Presents Data from REFR?ME-O1 Trial at SGO 2025
15 Mar 2025 //
GLOBENEWSWIRE
Sutro discards CEO, 50% of staff and lead ADC to save cash
15 Mar 2025 //
GLOBENEWSWIRE
Sutro To Present At TD Cowen 45th Annual Health Care Conference
03 Mar 2025 //
GLOBENEWSWIRE
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
30 Jan 2025 //
GLOBENEWSWIRE
Sutro, Boehringer Ingelheim Establish Commercial Cell-Free Tech
07 Jan 2025 //
GLOBENEWSWIRE
Sutro Biopharma Presents ADC Data at World ADC Conference
04 Nov 2024 //
GLOBENEWSWIRE
Sutro Bio Highlights ADC Innovation And Pipeline At Research Forum
10 Oct 2024 //
GLOBENEWSWIRE
Sutro Biopharma Announces Inducement Grant
20 Sep 2024 //
GLOBENEWSWIRE
Sutro Biopharma Announces Luvelta Combo Phase 1b Data At ESMO 2024
14 Sep 2024 //
GLOBENEWSWIRE
Sutro Biopharma To Host Research Forum On ADC Innovation October 10, 2024
11 Sep 2024 //
GLOBENEWSWIRE
Sutro Biopharma Initiates REFR?ME-L1 Phase 2 Trial For NSCLC
22 Aug 2024 //
GLOBENEWSWIRE
VGXI, Sutro Partner To Support Sutro`s Clinical Pipeline
03 Jun 2024 //
PR NEWSWIRE
Ipsen Inks Potential $900M Deal with Sutro for Global Rights to Preclinical ADC
03 Apr 2024 //
PRESS RELEASE
Sutro Bio Announces New Positive Data from the Compassionate Use of luvelta
11 Dec 2023 //
GLOBENEWSWIRE
Vaxcyte Enters into Manufacturing Rights Agreement with Sutro Biopharma
27 Nov 2023 //
GLOBENEWSWIRE
Sutro Demonstrates Meaningful ADC Innovation with Five Presentations
16 Oct 2023 //
GLOBENEWSWIRE
Sutro Biopharma and Blackstone Announce Royalty Financing Collaboration
26 Jun 2023 //
GLOBENEWSWIRE
Blackstone, Sutro ink royalty pact worth up to $390M biobucks
26 Jun 2023 //
FIERCE BIOTECH
Sutro Announces Presentation at ASCO Featuring Data for Luveltamab Tazevibulin
03 Jun 2023 //
GLOBENEWSWIRE
Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting ADC STRO-003
18 Apr 2023 //
GLOBENEWSWIRE
Sutro Biopharma Announces Update from STRO-002 Phase 1 Dose-Expansion Study
09 Jan 2023 //
GLOBENEWSWIRE
